KM 001
Alternative Names: KM-001Latest Information Update: 28 Nov 2019
Price :
$50 *
At a glance
- Originator Kainos Medicines
- Class Small molecules
- Mechanism of Action Diacylglycerol O-acyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Diabetes mellitus; Obesity
Most Recent Events
- 28 Nov 2019 No recent reports of development identified for research development in Diabetes-mellitus in South Korea (Parenteral)
- 28 Nov 2019 No recent reports of development identified for research development in Obesity in South Korea (Parenteral)
- 20 Oct 2015 Early research in Diabetes mellitus in South Korea (Parenteral)